Cargando…
Research led by people who use drugs: centering the expertise of lived experience
BACKGROUND: Research collaborations between people who use drugs (PWUD) and researchers are largely underutilized, despite the long history of successful, community-led harm reduction interventions and growing health disparities experienced by PWUD. PWUD play a critical role in identifying emerging...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454046/ https://www.ncbi.nlm.nih.gov/pubmed/34544478 http://dx.doi.org/10.1186/s13011-021-00406-6 |
_version_ | 1784570408784101376 |
---|---|
author | Salazar, Zach R. Vincent, Louise Figgatt, Mary C. Gilbert, Michael K. Dasgupta, Nabarun |
author_facet | Salazar, Zach R. Vincent, Louise Figgatt, Mary C. Gilbert, Michael K. Dasgupta, Nabarun |
author_sort | Salazar, Zach R. |
collection | PubMed |
description | BACKGROUND: Research collaborations between people who use drugs (PWUD) and researchers are largely underutilized, despite the long history of successful, community-led harm reduction interventions and growing health disparities experienced by PWUD. PWUD play a critical role in identifying emerging issues in the drug market, as well as associated health behaviors and outcomes. As such, PWUD are well positioned to meaningfully participate in all aspects of the research process, including population of research questions, conceptualization of study design, and contextualization of findings. MAIN BODY: We argue PWUD embody unparalleled and current insight to drug use behaviors, including understanding of novel synthetic drug bodies and the dynamics at play in the drug market; they also hold intimate and trusting relationships with other PWUD. This perfectly situates PWUD to collaborate with researchers in investigation of drug use behaviors and development of harm reduction interventions. While PWUD have a history of mistrust with the medical community, community-led harm reduction organizations have earned their trust and are uniquely poised to facilitate research projects. We offer the North Carolina Survivors Union as one such example, having successfully conducted a number of projects with reputable research institutions. We also detail the fallacy of meaningful engagement posed by traditional mechanisms of capturing community voice. As a counter, we detail the framework developed and implemented by the union in hopes it may serve as guidance for other community-led organizations. We also situate research as a mechanism to diversify the job opportunities available to PWUD and offer a real-time example of the integration of these principles into public policy and direct service provision. CONCLUSION: In order to effectively mitigate the risks posed by the fluid and volatile drug market, research collaborations must empower PWUD to play meaningful roles in the entirety of the research process. Historically, the most effective harm reduction interventions have been born of the innovation and heart possessed by PWUD; during the current overdose crisis, there is no reason to believe they will not continue to be. |
format | Online Article Text |
id | pubmed-8454046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84540462021-09-21 Research led by people who use drugs: centering the expertise of lived experience Salazar, Zach R. Vincent, Louise Figgatt, Mary C. Gilbert, Michael K. Dasgupta, Nabarun Subst Abuse Treat Prev Policy Commentary BACKGROUND: Research collaborations between people who use drugs (PWUD) and researchers are largely underutilized, despite the long history of successful, community-led harm reduction interventions and growing health disparities experienced by PWUD. PWUD play a critical role in identifying emerging issues in the drug market, as well as associated health behaviors and outcomes. As such, PWUD are well positioned to meaningfully participate in all aspects of the research process, including population of research questions, conceptualization of study design, and contextualization of findings. MAIN BODY: We argue PWUD embody unparalleled and current insight to drug use behaviors, including understanding of novel synthetic drug bodies and the dynamics at play in the drug market; they also hold intimate and trusting relationships with other PWUD. This perfectly situates PWUD to collaborate with researchers in investigation of drug use behaviors and development of harm reduction interventions. While PWUD have a history of mistrust with the medical community, community-led harm reduction organizations have earned their trust and are uniquely poised to facilitate research projects. We offer the North Carolina Survivors Union as one such example, having successfully conducted a number of projects with reputable research institutions. We also detail the fallacy of meaningful engagement posed by traditional mechanisms of capturing community voice. As a counter, we detail the framework developed and implemented by the union in hopes it may serve as guidance for other community-led organizations. We also situate research as a mechanism to diversify the job opportunities available to PWUD and offer a real-time example of the integration of these principles into public policy and direct service provision. CONCLUSION: In order to effectively mitigate the risks posed by the fluid and volatile drug market, research collaborations must empower PWUD to play meaningful roles in the entirety of the research process. Historically, the most effective harm reduction interventions have been born of the innovation and heart possessed by PWUD; during the current overdose crisis, there is no reason to believe they will not continue to be. BioMed Central 2021-09-20 /pmc/articles/PMC8454046/ /pubmed/34544478 http://dx.doi.org/10.1186/s13011-021-00406-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Salazar, Zach R. Vincent, Louise Figgatt, Mary C. Gilbert, Michael K. Dasgupta, Nabarun Research led by people who use drugs: centering the expertise of lived experience |
title | Research led by people who use drugs: centering the expertise of lived experience |
title_full | Research led by people who use drugs: centering the expertise of lived experience |
title_fullStr | Research led by people who use drugs: centering the expertise of lived experience |
title_full_unstemmed | Research led by people who use drugs: centering the expertise of lived experience |
title_short | Research led by people who use drugs: centering the expertise of lived experience |
title_sort | research led by people who use drugs: centering the expertise of lived experience |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454046/ https://www.ncbi.nlm.nih.gov/pubmed/34544478 http://dx.doi.org/10.1186/s13011-021-00406-6 |
work_keys_str_mv | AT salazarzachr researchledbypeoplewhousedrugscenteringtheexpertiseoflivedexperience AT vincentlouise researchledbypeoplewhousedrugscenteringtheexpertiseoflivedexperience AT figgattmaryc researchledbypeoplewhousedrugscenteringtheexpertiseoflivedexperience AT gilbertmichaelk researchledbypeoplewhousedrugscenteringtheexpertiseoflivedexperience AT dasguptanabarun researchledbypeoplewhousedrugscenteringtheexpertiseoflivedexperience |